Prolactin as a possible predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)

被引：0
|
作者：
Caponnetto, S. [1 ]
Mancini, M. L. [1 ]
Scagnoli, S. [1 ]
Barchiesi, G. [1 ]
Mosillo, C. [1 ]
Iannantuono, G. M. [1 ]
Verkhovskaia, S. [1 ]
Magri, V. [1 ]
Piesco, G. [1 ]
Pomati, G. [1 ]
Pellegrino, D. [1 ]
Urbano, F. [1 ]
Zancla, S. [1 ]
Manai, C. [1 ]
Cortesi, E. [1 ]
机构：
[1] Sapienza Univ Roma, Policlin Umberto 1, Oncol Med B, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw332.36
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A36
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer
    Maekura, Toshiya
    Naito, Maiko
    Tahara, Masahiro
    Ikegami, Naoya
    Kimura, Yohei
    Sonobe, Shoko
    Kobayashi, Takehiko
    Tsuji, Taisuke
    Minomo, Shojiro
    Tamiya, Akihiro
    Atagi, Shinji
    IN VIVO, 2017, 31 (05): : 1035 - 1039
  • [42] Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
    Wei, Jia
    Moran, Teresa
    Zou, Zhengyun
    Qian, Xiaoping
    Wang, Lifeng
    Camps, Carlos
    Hu, Wenjing
    Chaib, Imane
    Sanchez, Belen
    Xu, Lixia
    Karachaliou, Niki
    Sanchez-Ronco, Maria
    Liu, Baorui
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 180 - 188
  • [43] Liquid Biopsies First to Make Treatment Decisions in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC)
    Raez, L. E.
    Brice, K.
    Tsai, J.
    Drusbosky, L.
    Dumais, K.
    Lopez-Cohen, A.
    Wietecha, D.
    Daba, H.
    Izquierdo, P.
    Santos, E. S.
    Powery, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S578 - S579
  • [44] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [46] EVALUATION OF WHITE BLOOD CELL GROWTH FACTOR (WBCGF) USE IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Hoverman, J. R.
    Sheth, S.
    Clayton, M.
    Garey, J.
    Beveridge, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 425 - 426
  • [47] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [48] Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer
    Genova, Carlo
    Carrega, Paolo
    Distefano, Roberta
    Ottonello, Selene
    Pietra, Gabriella
    Cossu, Irene
    Rijavec, Erika
    Biello, Federica
    Rossi, Giovanni
    Barletta, Giulia
    Dal Bello, Maria Giovanna
    Alama, Angela
    Coco, Simona
    Vanni, Irene
    Maggioni, Claudia
    Merlo, Franco
    Mingari, Maria Cristina
    Grosse, Francesco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1320 - S1321
  • [49] Double Lung Transplantation in Patients with Metastatic Lung-limited Non-Small Cell Lung Carcinoma (NSCLC)
    Chae, Y. K.
    Demir, T.
    Chung, L. I. -Y.
    Woo, W.
    Moloney, C.
    Sanson, B.
    Dwyer, R.
    Jung, C. M.
    Tomic, R.
    Bharat, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S187 - S187
  • [50] Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
    Tanaka, Kentaro
    Chamoto, Kenji
    Saeki, Sho
    Hatae, Ryusuke
    Ikematsu, Yuki
    Sakai, Kazuko
    Ando, Nobuhisa
    Sonomura, Kazuhiro
    Kojima, Shinsuke
    Taketsuna, Masanori
    Kim, Young Hak
    Yoshida, Hironori
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Hirano, Tomoko
    Matsuda, Fumihiko
    Hirai, Toyohiro
    Nishio, Kazuto
    Sakagami, Takuro
    Fukushima, Masanori
    Nakanishi, Yoichi
    Honjo, Tasuku
    Okamoto, Isamu
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (675)
12345